N
Nagarajan Kannan
Researcher at Mayo Clinic
Publications - 62
Citations - 1858
Nagarajan Kannan is an academic researcher from Mayo Clinic. The author has contributed to research in topics: Medicine & Biology. The author has an hindex of 24, co-authored 46 publications receiving 1476 citations. Previous affiliations of Nagarajan Kannan include University of Auckland & BC Cancer Agency.
Papers
More filters
Journal ArticleDOI
ΔNp63 promotes stem cell activity in mammary gland development and basal-like breast cancer by enhancing Fzd7 expression and Wnt signalling
Rumela Chakrabarti,Yong Wei,Julie Hwang,Xiang Hang,Mario Andres Blanco,Mario Andres Blanco,Abrar Choudhury,Benjamin Tiede,Rose-Anne Romano,Christina DeCoste,Laura Mercatali,Toni Ibrahim,Dino Amadori,Nagarajan Kannan,Connie J. Eaves,Satrajit Sinha,Yibin Kang +16 more
TL;DR: It is shown that the ΔNp63 isoform of the Trp63 transcription factor promotes normal mammary stem cell activity by increasing the expression of the Wnt receptor Fzd7, thereby enhancing Wnt signalling and governs tumour-initiating activity of the basal subtype of breast cancer.
Journal ArticleDOI
Barcoding reveals complex clonal dynamics of de novo transformed human mammary cells
Long V. Nguyen,Davide Pellacani,Davide Pellacani,Sylvain Lefort,Nagarajan Kannan,Nagarajan Kannan,Tomo Osako,Tomo Osako,Maisam Makarem,Claire Cox,William Kennedy,Philip A. Beer,Annaick Carles,Michelle Moksa,Misha Bilenky,Misha Bilenky,Sneha Balani,Sonja Babovic,Ivan Y. Sun,Ivan Y. Sun,Miriam P. Rosin,Miriam P. Rosin,Samuel Aparicio,Samuel Aparicio,Martin Hirst,Martin Hirst,Connie J. Eaves,Connie J. Eaves +27 more
TL;DR: In this article, the authors presented the first formal evidence of the shared and independent ability of basal cells and luminal progenitors, isolated from normal human mammary tissue and transduced with a single oncogene (KRAS(G12D)), to produce serially transplantable, polyclonal, invasive ductal carcinomas within 8 weeks of being introduced either subrenally or subcutaneously into immunodeficient mice.
Journal ArticleDOI
Are trefoil factors oncogenic
TL;DR: Trefoil factors (TFFs) are classical estrogen-regulated genes and have served as markers of estrogen gene regulation by various environmental estrogens as discussed by the authors, and are also regulated by several other factors including growth hormone (hGH), insulin-like growth factor-1 (IGF-1), epidermal growth factor (EGF) and various oncogenic stimuli.
Journal ArticleDOI
Progesterone and Breast Cancer.
TL;DR: A review of the evidence that links progesterone to breast cancer risk and future directions for filling current gaps in knowledge are suggested.
Journal ArticleDOI
Analysis of Normal Human Mammary Epigenomes Reveals Cell-Specific Active Enhancer States and Associated Transcription Factor Networks.
Davide Pellacani,Misha Bilenky,Nagarajan Kannan,Alireza Heravi-Moussavi,David J.H.F. Knapp,Sitanshu Gakkhar,Michelle Moksa,Annaick Carles,Richard A. Moore,Andrew J. Mungall,Marco A. Marra,Steven J.M. Jones,Samuel Aparicio,Samuel Aparicio,Martin Hirst,Martin Hirst,Connie J. Eaves +16 more
TL;DR: An epigenomic comparison of these three subsets with one another, with their associated stromal cells, and with three immortalized, non-tumorigenic human mammary cell lines shows that each cell type has unique features, primarily within genomic regulatory regions, and that the cell lines group together.